FIELD: biotechnology.
SUBSTANCE: invention relates to identification of enzyme used for production of preparation for anti-tumor agent delivery, wherein said agents are selectively converted to active substances in tumor tissue or cells. Primarily gene expression levels in healthy tissues or normal cells are compared with gene expression levels in human tumor tissue or tumor originated cells. Further enzyme is selected which has expression level in tumor tissue or cells exceeding expression level in healthy tissues or normal cells by two or more time. Preparation for anti-cancer agent delivery is prepared. Namely cells are cultivated in presence or in absence of tested compound wherein cDNA of identified enzyme is included into abovementioned cells. Then ability of tested agent to selectively convert into active substance in tumors is determined.
EFFECT: method for tumor treatment without side effects.
14 cl, 50 ex
Title | Year | Author | Number |
---|---|---|---|
HEXACYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND THEIR USING AS ANTITUMOR AGENTS, METHOD FOR PREPARING HEXACYCLIC COMPOUNDS | 2002 |
|
RU2299212C2 |
NOVEL WATER-SOLUBLE PRODRUGS | 2005 |
|
RU2413731C2 |
HEXACYCLIC COMPOUND | 1992 |
|
RU2071476C1 |
PHARMACEUTICAL COMPOSITIONS COMPRISING POLYSACCHARIDE CONJUGATES FOR INHIBITION OF METASTASIS OR PROPHYLAXIS IN MALIGNANT TUMOR RELAPSE | 2002 |
|
RU2275913C2 |
LIGAND-DRUG CONJUGATE OF EXATECAN ANALOGUE, ITS PRODUCTION METHOD AND ITS USE | 2019 |
|
RU2793316C2 |
CAMPTOTHECIN ANALOGS, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2190613C2 |
CAMPOTECIN COMPOUNDS, METHODS OF PREPARATION THEREOF, INTERMEDIATES, AND THERAPEUTIC COMPOSITIONS | 1996 |
|
RU2164515C2 |
PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
ETHYLENEDIAMINE DERIVATIVES AND FXa INHIBITOR AND ANTICOAGULANT COMPRISING THEREOF | 2001 |
|
RU2268259C2 |
DERIVATIVES OF AROYLPIPERAZINE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT | 1998 |
|
RU2258702C2 |
Authors
Dates
2008-03-20—Published
2002-11-18—Filed